Law Calvin H L, Wright Frances C, Rapanos Theodore, Alzahrani Mohamed, Hanna Sherif S, Khalifa Mahmoud, Smith Andrew J
The Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.
J Surg Oncol. 2003 Nov;84(3):120-6. doi: 10.1002/jso.10309.
A minimum number of lymph nodes must be assessed for accurate diagnosis of stage II colon cancer. We assessed number of lymph nodes retrieved, pathological ultra-staging, and outcome in stage II colon cancer.
Consecutively treated patients with stage II colon cancer were identified. Baseline and outcome data were collected. Retrospective ultra-staging using lymphovascular invasion (LVI) and nodal micrometastases was performed. Patients were divided into two groups: group I had <or=6 nodes and group II had >6 nodes retrieved. Survival was analyzed.
One hundred and fifteen patients were included in the study. The 5 year overall survival was worse in group I versus II (P = 0.03). LVI and micrometastases were identified but neither predicted survival. Disease failure in group I was due to distant metastases rather than local recurrence.
Inadequate retrieval and assessment of lymph nodes is associated with worse outcome in stage II colon cancer patients. Recurrence patterns support the hypothesis that disease recurrence occurred due to inaccurate staging. In this small study, LVI or nodal micrometastases did not predict survival. Maximal attention should be paid to the total number of lymph nodes retrieved before embarking on potentially more resource intensive staging methods.
为准确诊断II期结肠癌,必须评估最少数量的淋巴结。我们评估了II期结肠癌患者的淋巴结获取数量、病理超分期及预后。
确定连续接受治疗的II期结肠癌患者。收集基线和预后数据。采用淋巴管侵犯(LVI)和淋巴结微转移进行回顾性超分期。患者分为两组:I组获取的淋巴结数≤6个,II组获取的淋巴结数>6个。分析生存率。
115例患者纳入研究。I组的5年总生存率低于II组(P = 0.03)。发现了LVI和微转移,但两者均未预测生存率。I组的疾病失败是由于远处转移而非局部复发。
II期结肠癌患者淋巴结获取和评估不足与较差的预后相关。复发模式支持疾病复发是由于分期不准确这一假说。在这项小型研究中,LVI或淋巴结微转移未预测生存率。在采用可能更耗费资源的分期方法之前,应高度重视获取的淋巴结总数。